Avita Medical

Avita Medical
Avita Medical
Type Public company (ASX: AVH)
Industry Regenerative medicine
Founded 1993 (1993)
Founder(s) Fiona Wood
Headquarters Perth, Western Australia
Cambridge, United Kingdom
Woburn, Massachusetts, USA
Area served Global
Key people William F. Dolphin, CEO
Products Artificial skin
Website avitamedical.com

Avita Medical (ASX: AVH) develops spray-on skin processes to treat skin trauma, including burns. They market their artificial skin products under the names CellSpray and ReCell.[1] According to Avita, ReCell has been approved for marketing and sale in Europe, Canada and Australia.[2]

Originally named "Clinical Cell Culture" (ASX: C3), the company restructured under the name "Avita Medical" in June 2008 with a new CEO, William Dolphin.

US Government grant

In 2009 the United States Armed Forces Institute of Regenerative Medicine provided Avita with a US$1.45 million grant to hasten the approval of the ReCell kit with the U.S. Food and Drug Administration.[3]

References

  1. ^ "Spray-on skin speeds up healing burns" Australian Broadcasting Corporation November 23, 2009.
  2. ^ "Avita Medical - Recell" Accessed February 18, 2011.
  3. ^ "Avita boosted by US affirmation" The Age May 27, 2009.



Stub icon This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.